The effects of 860 MHz radiofrequency radiation on the induction or promotion of brain tumors and other neoplasms in rats.
Sprague-Dawley rats were irradiated with a continuous- wave (CW) or a pulsed-wave (P) radiofrequency (RF) for 6 h/day, 5 days/week from 2 up to 24 months of age. The RFs emanated from dipole antennas (1 W average output) 2.0 +/- 0.5 cm from the tip of each rat's nose. The RFs had an 860 MHz frequency, and the specific absorption rate was 1.0 W/ kg averaged over the brain. Fifteen groups of 60 rats (900 total) were formed from offspring of females injected i.v. with 0 (groups 1, 2, 9, 10, 13), 2.5 (groups 5, 6, 7, 8, 11, 12, 14) or 10 mg/kg (groups 3, 4, 15) ethylnitrosourea (ENU) to induce brain tumors. Groups 1, 3, 5 and 7 received the PRF, and groups 9 and 11 the CWRF; groups 2, 4, 6, 8, 10 and 12 were sham-irradiated, and groups 13-15 were cage controls. All rats but 2, totaling 898, were necropsied, and major tissues were studied histopathologically. There was no statistically significant evidence that the PRF or CWRF induced neoplasia in any tissues. Additionally, there was no significant evidence of promotion of cranial or spinal nerve or spinal cord tumors. The PRF or CWRF had no statistically significant effect on the number, volume, location, multiplicity, histological type, malignancy or fatality of brain tumors. There was a trend for the group that received a high dose of ENU and was exposed to the PRF to develop fatal brain tumors at a higher rate than its sham group; however, the result was not significant using the log-rank test (P = 0.14, 2-tailed). No statistically significant differences were related to the PRF or CWRF compared to controls in the low- or zero-dose groups regarding tumors of any kind.
Department of Pathology, The George Washington University, Ross Hall B-12, 2300 I Street NW, Washington, D.C. 20037, USA.
B C
BC
Zook
S J
SJ
Simmens
D000818:Animals; D001932:Brain Neoplasms / Q000139:chemically induced / Q000209:etiology*; D040421:Cell Phone / Q000295:instrumentation; D003390:Cranial Nerve Neoplasms / Q000139:chemically induced / Q000209:etiology; D005038:Ethylnitrosourea / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D005910:Glioma / Q000139:chemically induced / Q000209:etiology*; D008297:Male; D009369:Neoplasms / Q000139:chemically induced / Q000209:etiology; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D009442:Neurilemmoma / Q000139:chemically induced / Q000209:etiology; D010524:Peripheral Nervous System Neoplasms / Q000139:chemically induced / Q000209:etiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011846:Radio Waves / Q000009:adverse effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013120:Spinal Cord Neoplasms / Q000139:chemically induced / Q000209:etiology; D013127:Spinal Nerves
D005038:Ethylnitrosourea